Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

PB101

  • You have access
    Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer Models
    MINSUNG PARK, CHENG HYUN LEE, KUI-JIN KIM, SUNG-HYUN HWANG, JI HEA SUNG, MILANG NAM, MINSU KANG, WOOCHAN PARK, JI-WON KIM, JIN WON KIM, SE HYUN KIM, JEONGMIN SEO, EUN HEE JUNG, KOUNG JIN SUH, YU JUNG KIM, JEE HYUN KIM, HYE SEONG LIM, HYUN GUL YANG, EUN BYUL CHO and KEUN-WOOK LEE
    Anticancer Research May 2026, 46 (5) 2429-2443; DOI: https://doi.org/10.21873/anticanres.18128
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire